.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,750,703

« Back to Dashboard

Details for Patent: 5,750,703

Title: Piperidine derivatives and process for their production
Abstract:The present invention relates to a process for preparation of substantially pure piperidine derivative compounds of the formulae: ##STR1## wherein R.sub.1 is hydrogen or hydroxy; R.sub.2 is hydrogen; or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ; R.sub.3 is --COOH or --COOR.sub.4 ; R.sub.4 has 1 to 6 carbon atoms; A, B, and D are the substituents of their respective rings each of which may be different or the same and are hydrogen, halogens, alkyl, hydroxy, alkoxy, or other substituents.
Inventor(s): D'Ambra; Thomas E. (Wynantskill, NY)
Assignee: Albany Molecular Research, Inc. (Albany, NY)
Filing Date:Feb 02, 1995
Application Number:08/382,649
Claims:1. A process of preparing a piperidine derivative compound of the formula: ##STR42## wherein R.sub.1 is hydrogen or hydroxy;

R.sub.2 is hydrogen;

or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ;

R.sub.3 is --COOH or --COOR.sub.4 ;

R.sub.4 has 1 to 6 carbon atoms;

A, B, and D are the substituents of their aromatic rings, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, or other substituents,

said process comprising:

providing a substantially pure regioisomer of the following formula: ##STR43## converting the substantially pure regioisomer to the piperidine derivative compound with a piperidine compound of the formula: ##STR44## .

2. A process according to claim 1, wherein said providing comprises:

acylating a starting compound of the formula: ##STR45## wherein R.sub.5 is OR.sub.6, --N(R.sub.6).sub.2, and --SR.sub.6, and

R.sub.6 is an alkyl with 1 to 6 carbons,

with a compound of the formula: ##STR46## wherein X is a halogen,

under conditions effective to produce a first mixture of regioisomers of the formula: ##STR47## hydrolyzing the first mixture of regioisomers under conditions effective to form a second mixture of a regioisomers of the formula: ##STR48## recovering from the second mixture of regioisomers the substantially pure regioisomer of the formula: ##STR49##

3. A process according to claim 2, wherein said recovering comprises:

crystallizing from the second mixture of regioisomers a substantially pure regioisomer salt of the formula: ##STR50## wherein X.sup.+ is a Lewis Acid; isolating the substantially pure regioisomer salt; and

converting the substantially pure regioisomer salt to the substantially pure regioisomer of the formula: ##STR51##

4. A process according to claim 3, wherein X.sup.+ is an alkali metal salt or an ammonium salt of the form NR.sub.7 R.sub.8 R.sub.9 wherein R.sub.7, R.sub.8, and R.sub.9 are individually hydrogen or a straight or branched alkyl of 1 to 6 carbon atoms, or an alkyl substituted at any position with a phenyl ring or a substituted phenyl ring.

5. A process according to claim 2, wherein said acylating is carried out by a Friedel-Crafts reaction using AlCl.sub.3 catalyst.

6. A process according to claim 1 further comprising:

reducing the piperidine derivative under conditions effective to form a hydroxylated piperidine derivative of the formula: ##STR52##

7. A process according to claim 6, wherein the hydroxylated piperidine derivative has the formula: ##STR53##

8. A process according to claim 6, wherein the hydroxylated piperidine derivative has the formula: ##STR54##

9. A process according to claim 1, wherein said converting comprises:

halogenating the substantially pure regioisomer of the following formula: ##STR55## under conditions effective to form a first intermediate compound of the formula: ##STR56## wherein X is a halogen and

reacting the first intermediate compound with a piperidine compound of the formula: ##STR57## under conditions effective to form the piperidine derivative of the following formula: ##STR58##

10. A process according to claim 1, wherein said converting comprises:

reacting the substantially pure regioisomer of the following formula: ##STR59## with a piperidine compound of the formula: ##STR60## under conditions effective to form the piperidine derivative of the formula: ##STR61##

11. A process according to claim 1, wherein the piperidine derivative has the formula: ##STR62##

12. A process according to claim 1, wherein the piperidine derivative has the formula: ##STR63##
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc